Arif Hussain

6.0k total citations · 1 hit paper
167 papers, 3.9k citations indexed

About

Arif Hussain is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Arif Hussain has authored 167 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Pulmonary and Respiratory Medicine, 68 papers in Oncology and 51 papers in Molecular Biology. Recurrent topics in Arif Hussain's work include Prostate Cancer Treatment and Research (86 papers), Prostate Cancer Diagnosis and Treatment (29 papers) and Radiopharmaceutical Chemistry and Applications (18 papers). Arif Hussain is often cited by papers focused on Prostate Cancer Treatment and Research (86 papers), Prostate Cancer Diagnosis and Treatment (29 papers) and Radiopharmaceutical Chemistry and Applications (18 papers). Arif Hussain collaborates with scholars based in United States, United Kingdom and Canada. Arif Hussain's co-authors include C. Daniel Mullins, Eberechukwu Onukwugha, Brian Seal, Candice Yong, Eric J. Small, Nicholas J. Vogelzang, Susan Halabi, M. Saeed Sheikh, Joseph A. Fontana and Jianfei Qi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Physical Review Letters and Nucleic Acids Research.

In The Last Decade

Arif Hussain

160 papers receiving 3.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer

2014 511 citations Arif Hussain, C. Daniel Mullins et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arif Hussain United States	29	1.7k	1.4k	1.3k	671	534	167	3.9k
Shailendra Verma Canada	33	1.3k 0.7×	2.7k 1.9×	781 0.6×	846 1.3×	553 1.0×	177	4.8k
Dirk Vordermark Germany	37	1.2k 0.7×	1.1k 0.8×	1.4k 1.1×	1.1k 1.7×	713 1.3×	222	4.7k
Michelle Melisko United States	34	1.0k 0.6×	2.1k 1.5×	802 0.6×	373 0.6×	551 1.0×	170	4.5k
Rachel Cannady United States	18	1.0k 0.6×	2.7k 1.9×	866 0.7×	702 1.0×	237 0.4×	26	4.8k
Mourad Tighiouart United States	38	930 0.5×	1.7k 1.3×	1.6k 1.3×	700 1.0×	311 0.6×	152	5.0k
Tanya B. Dorff United States	36	1.9k 1.1×	1.6k 1.1×	1.4k 1.1×	820 1.2×	430 0.8×	288	5.2k
Ondřej Topolčan Czechia	31	1.0k 0.6×	1.6k 1.1×	1.3k 1.0×	1.1k 1.6×	278 0.5×	254	4.2k
Kexin Sun China	24	874 0.5×	1.3k 1.0×	1.0k 0.8×	623 0.9×	326 0.6×	85	3.9k
Philip J. Stella United States	39	2.1k 1.2×	3.3k 2.4×	1.0k 0.8×	780 1.2×	258 0.5×	126	5.6k
Xiaoyu Jia United States	28	1.4k 0.8×	1.4k 1.0×	491 0.4×	730 1.1×	415 0.8×	65	3.2k

Countries citing papers authored by Arif Hussain

Since Specialization

Citations

This map shows the geographic impact of Arif Hussain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arif Hussain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arif Hussain more than expected).

Fields of papers citing papers by Arif Hussain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arif Hussain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arif Hussain. The network helps show where Arif Hussain may publish in the future.

Co-authorship network of co-authors of Arif Hussain

This figure shows the co-authorship network connecting the top 25 collaborators of Arif Hussain. A scholar is included among the top collaborators of Arif Hussain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arif Hussain. Arif Hussain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Wenting, Shiwen Zhang, Lina Liu, et al.. (2025). State of Health Estimation and Battery Management: A Review of Health Indicators, Models and Machine Learning. Materials. 18(1). 145–145. 5 indexed citations

Afroze, Nazia, et al.. (2025). Long non-coding RNA involved in the carcinogenesis of human female cancer - a comprehensive review. Discover Oncology. 16(1). 122–122. 1 indexed citations

Hussain, Arif, et al.. (2024). Potential barriers to implementation of next-generation sequencing in cancer management: a U.S. Physician-based survey. Future Oncology. 21(2). 231–239.

Malek, Rana, et al.. (2024). Targeting androgen biosynthesis in prostate cancer: implications on endocrine physiology. Current Opinion in Oncology. 36(3). 195–201. 1 indexed citations

Pan, Elizabeth, Wanling Xie, Archana Ajmera, et al.. (2023). A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE). Molecular Cancer Therapeutics. 22(4). 511–518. 29 indexed citations

Rana, Zaker, Jason K. Molitoris, Matthew J. Ferris, et al.. (2023). Phase 2 randomized total eradication of metastatic lesions following definitive radiation to the prostate in de novo oligometastatic prostate cancer (TERPs) trial.. Journal of Clinical Oncology. 41(6_suppl). TPS275–TPS275. 1 indexed citations

Shah, Neal, Matthew T. Campbell, Shifeng Mao, et al.. (2023). 1889P Phase Ib/II study of batiraxcept (BT, AVB-S6-500, an AXL pathway inhibitor) in combination with cabozantinib (cabo) in patients with advanced clear cell renal cell carcinoma (ccRCC) who failed first-line (1L) therapy. Annals of Oncology. 34. S1016–S1017.

Jani, Chinmay, Wanling Xie, Archana Ajmera, et al.. (2023). A phase 1/2 study of combination olaparib and radium-223 in men with metastatic castration-resistant prostate cancer with bone metastases (COMRADE): A trial in progress.. Journal of Clinical Oncology. 41(16_suppl). TPS5110–TPS5110.

Khan, Mohd Sajid, et al.. (2023). Non Decompressive Single Stage Bilateral Craniotomy in Traumatic Brain Injury. 17(1). 333–335. 1 indexed citations

10.

Johnson, Courtney, et al.. (2020). Medical oncology referral and systemic therapy of patients with advanced stage urothelial carcinoma. Journal of Comparative Effectiveness Research. 9(13). 945–957. 1 indexed citations

11.

Kaiser, Adeel, John G. Eley, Stephanie R. Rice, et al.. (2019). Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies. Journal of Visualized Experiments. 12 indexed citations

12.

Shapiro, Jeremy, Ray McDermott, Josep M. Piulats, et al.. (2019). Abstract 727: Comprehensive genomic profiling of >1000 plasma and tumor tissue samples from metastatic castration-resistant prostate cancer (mCRPC) patients gives insight into targeted treatment strategies. Cancer Research. 79(13_Supplement). 727–727. 1 indexed citations

13.

Bahaj, Waled, Kevin F. Kennedy, Timothy Pluard, et al.. (2018). Correlation of Somatic Genomic Alterations Between Tissue Genomics and ctDNA Employing Next-Generation Sequencing: Analysis of Lung and Gastrointestinal Cancers. Molecular Cancer Therapeutics. 17(5). 1123–1132. 19 indexed citations

14.

Howard, James L., Michelle L. Bookstaver, Tek N. Lamichhane, et al.. (2017). Engineered Multivalency Enhances Affibody-Based HER3 Inhibition and Downregulation in Cancer Cells. Molecular Pharmaceutics. 14(4). 1047–1056. 25 indexed citations

15.

Zhang, Yanting, Rena G. Lapidus, Peiyan Liu, et al.. (2016). Targeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdA. Molecular Cancer Therapeutics. 15(7). 1504–1514. 32 indexed citations

16.

Rutenberg, Michael S., et al.. (2016). Salvage external beam radiotherapy for locally recurrent prostate cancer after definitive brachytherapy. Brachytherapy. 15(6). 722–729. 15 indexed citations

17.

Xie, Yi, Takeo Nakanishi, Karthika Natarajan, et al.. (2015). Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1849(3). 317–327. 12 indexed citations

18.

Kumar, Sameera, et al.. (2014). The Efficacy and Toxicity Outcomes of HIV-Infected Patients With Prostate Cancer Treated With Definitive Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 90(1). S452–S453. 1 indexed citations

19.

Hussain, Arif, C. Daniel Mullins, Yi Qian, et al.. (2014). Burden and Timing of First and Subsequent Skeletal Related Events (SRES) in United States Elderly Men with Metastatic Prostate Cancer (MPC). Value in Health. 17(3). A72–A72. 2 indexed citations

20.

Tang, Yaoliang, Linbo Wang, Olga Goloubeva, et al.. (2009). The relationship of neuroendocrine carcinomas to anti‐tumor therapies in TRAMP mice. The Prostate. 69(16). 1763–1773. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact